Cough-assisted Devices Global Market to Register Incremental Growth at a CAGR of ~7% by 2028 | DelveInsight

The cough-assisted device market is gaining traction as the prevalence of various neuromuscular illnesses increases globally. Furthermore, the growth in spinal cord injuries, advantages of devices over manual cough help techniques, and an increase in product approval of cough assist devices, among other factors, are expected to boost the global cough-assisted devices market.

LAS VEGAS, Aug. 16, 2023 /PRNewswire/ -- DelveInsight's Cough-assisted Devices Market Insights report provides the current and forecast market analysis, individual leading cough-assisted devices companies' market shares, challenges, cough-assisted devices market drivers, barriers, trends, and key market cough-assisted devices companies in the market.

Key Takeaways from the Cough-assisted Devices Market Report

• As per DelveInsight estimates, North America is anticipated to dominate the global cough-assisted devices market during the forecast period. 
• Notable cough-assisted devices companies such as Koninklijke Philips N.V., Hill-Rom Services, Inc. (Baxter), Dima Italia Srl, United Hayek Industries Inc., Ventec Life Systems, Air Liquide Medical Systems, Breas Medical Ltd, ABM Respiratory Care, and several others, are currently operating in the cough-assisted devices market.
• In July 2020, Hillrom launched two new respiratory therapy devices: the Volara™ System, which provides hospital-grade oscillation and lung expansion (OLE) therapy, and the Synclara™ Cough System (a non-invasive therapy that simulates a cough to remove secretions in patients with compromised peak cough flow).
• In March 2020, ABM Respiratory Care received FDA clearance for BiWaze Cough, a device intended for clearing bronchopulmonary secretions.

To read more about the latest highlights related to the cough-assisted devices market, get a snapshot of the key highlights entailed in the Global Cough-assisted Devices Market Report

Cough-assisted Devices Overview

Cough-assisted devices are innovative medical tools designed to aid individuals with impaired cough function, often seen in conditions such as neuromuscular disorders, spinal cord injuries, or certain respiratory diseases. These devices employ a combination of techniques, such as mechanical oscillations or positive pressure, to help stimulate and enhance the natural cough reflex. By facilitating the clearance of mucus and other respiratory secretions, cough-assisted devices play a crucial role in preventing complications like pneumonia and improving overall lung health. These devices not only alleviate the physical burden on patients but also contribute to a better quality of life by promoting respiratory hygiene and reducing the risk of respiratory infections. As technology continues to advance, cough-assisted devices are becoming more effective, portable, and user-friendly, offering new possibilities for enhancing respiratory care and empowering individuals with compromised cough abilities.

Cough-assisted Devices Market Insights

North America is likely to hold a significant proportion of the overall cough-assisted devices market in the coming years. This dominance is due to a rising prevalence of the population suffering from numerous neuromuscular illnesses, spinal cord injuries, and other conditions that impact and weaken the muscles. Furthermore, the existence of important manufacturers in the region, as well as the availability of well-established healthcare institutions, would all contribute to the regional cough-assisted devices market growth. Furthermore, the region's manufacturers' ongoing attempts to develop innovative cough-assisted devices are expected to boost the market.

To know more about why North America is leading the market growth in the cough-assisted devices market, get a snapshot of the Cough-assisted Devices Market Outlook 

Cough-assisted Devices Market Dynamics

The increased burden of patients suffering from various neuromuscular disorders is principally responsible for the rise in demand for cough-assisted devices. This is because neuromuscular problems weaken the muscles, causing patients to be unable to adequately remove secretions, increasing the necessity for these devices. Furthermore, spinal cord injuries in the mid-cervical vertebrae (C3, C4, and C5) disrupt the breathing muscles, which may increase product demand.

However, certain factors, such as the demanding regulatory process for device clearance and the expensive cost of devices, are anticipated to stymie the global cough-assisted devices market's expansion.

In addition, the exceptional COVID-19 outbreak has hampered the cough-assisted devices market. This is due to the fact that COVID-19 is primarily transmitted through droplets produced by coughing or sneezing. Cough assist and other airway clearance equipment can "aerosolize" the COVID-19 virus, spreading it considerably further. The introduction of numerous vaccinations and widespread immunization campaigns around the world, on the other hand, is likely to normalize the post-pandemic environment.

Get a sneak peek at the cough-assisted devices market dynamics @ Cough-assisted Devices Market Dynamics Analysis

Cough-assisted Devices Market Assessment

• Cough-assisted Devices Market Segmentation
• Cough-assisted Devices Market Segmentation By End User: Hospitals, Home Care Settings, and Others
• Cough-assisted Devices Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View

Which MedTech key players in the cough-assisted devices market are set to emerge as the trendsetter explore @ Cough-assisted Devices Companies 

Table of Contents 

Interested in knowing the cough-assisted devices market by 2028? Click to get a snapshot of the Cough-assisted Devices Market Trends

Related Reports

Amyotrophic Lateral Sclerosis Pipeline

Amyotrophic Lateral Sclerosis Pipeline Insight – 2023 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key amyotrophic lateral sclerosis companies, including Biogen, Ionis Pharmaceuticals, Ferrer Internacional S.A., AbbVie, Calico Life Sciences LLC, Genuv Inc., Kadimastem, Corcept Therapeutics, AL-S Pharma, Rapa Therapeutics LLC, Cytokinetics, MediciNova, Retrotope, Inc. Woolsey Pharmaceuticals, Sanofi, PTC Therapeutics, Helixmith Co., Ltd., Annexon, Inc., Denali Therapeutics Inc., Revalesio Corporation, Clene Nanomedicine, Ashvattha Therapeutics, Inc., Apellis Pharmaceuticals, Inc., Procypra Therapeutics, Knopp Biosciences, InFlectis BioScience, AI Therapeutics, Inc., Cellenkos, ZZ Biotech, LLC, QurAlis Corporation, Alector Inc., NeuroSense Therapeutics Ltd., Novartis Pharmaceuticals, Eledon Pharmaceuticals, among others.

Multiple Sclerosis Pipeline

Multiple Sclerosis Pipeline Insight – 2023 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key multiple sclerosis companies, including TG Therapeutics, Immunic, Atara Biotherapeutics, ANOKION, ImStem Biotechnology, Merck Serono, CinnaGen, Immune Response BioPharma, Inc., Clene Nanomedicine, GeNeuro SA, Sanofi, Bristol-Myers Squibb, HuniLife Biotechnology, Inc., Emerald Health Pharmaceuticals, Biogen, RemeGen Co., Ltd., Antisense Therapeutics, Immune Response BioPharma, Biocad, AB Science, Genentech, Novartis, Pipeline Therapeutics, ASLAN Pharmaceuticals, GlaxoSmithKline, Lucid Psycheceuticals, Voronoi, Hanmi Pharmaceutical, Mapi Pharma, f5 Therapeutics, Autobahn Therapeutics, AstraZeneca, ZyVersa Therapeutics, RedHill Biopharma, Gossamer Bio, Sarepta Therapeutics, BrainStorm Cell Limited, CytoDyn, Pear Therapeutics, ABION, among others.

Myasthenia Gravis Market

Myasthenia Gravis Market Insight, Epidemiology, and Market Forecast – 2032 report delivers an in-depth understanding of the market trends, market drivers, market barriers, and key myasthenia gravis companies, including Viela Bio, UCB Pharma, Momenta Pharmaceuticals, Sanofi, Regeneron Pharmaceuticals, Ra Pharmaceuticals, Hoffmann-La Roche, Alexion Pharmaceuticals, Catalyst Pharmaceuticals, Harbour BioMed, Novartis, Takeda, DAS Therapeutics, RemeGen, Cartesian Therapeutics, Nanjing IASO Biotherapeutics, Cabaletta Bio, CytoDyn, Ahead Therapeutics, Toleranzia, Rallybio, among others.

Myositis Pipeline

Myositis Pipeline Insight – 2023 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key myositis companies, including GlaxoSmithKline, Corbus Pharmaceuticals, Abcuro, Inc., Orphazyme, Bristol-Myers Squibb, Kezar Life Sciences, Inc., Horizon Therapeutics, Viela Bio, Paean Biotechnology Inc., Alexion Pharmaceuticals, Janssen Biotech, CSL Behring, Pfizer, Roche, among others.

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. 

Contact Us
Shruti Thakur
info@delveinsight.com  
+1(919)321-6187
https://www.delveinsight.com/medical-devices 

Logo: https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg